2023-09-14 12:13:37
New molecules intended to improve blood sugar control and promote weight loss have recently been approved by regulatory authorities in Europe and the United States before being placed on the market. These include glucagon-like peptide-1 (GLP-1) analogues, incretin hormones potentiating the effect of glucose on insulin secretion), which are attracting the interest of clinicians, patients and the general public.
This class of drugs is now also used by people who do not face real weight management problems and by non-diabetic patients.
Are you knowledgeable regarding GLP-1 analogues (agonists) such as semaglutide (Ozempic ®) and dulaglutide (Trucilily ®)? The point, in 5 questions.
1694694411
#Quiz #GLP1 #analogues
